StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Do not forget this qoute on JAN 7 2021

<< Previous

Bullboard Posts

Next >>

Comment by Jonnyboy85on Feb 08, 2021 1:28pm

96 Views

Post# 32502424

RE:RE:Do not forget this qoute on JAN 7 2021

Caught empty handed huh? Sad you would throw your lot in with the rest of the vagrants bashing our stock so you can get back in. Thought you were above it.

SAGDollar wrote: Im still bitter regarding the "bolus of revenue" which was a blatant lie from a year and a half ago. Fool me once shame on you. Fool me twice shame on me.

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity